Mylan Dodges Contract Breach Claim In Takeda IP Fight
A Delaware federal judge on Wednesday agreed to hand Mylan a win on a breach of contract claim from Takeda Pharmaceuticals USA Inc. over its gout drug Colcrys, agreeing with Mylan's...To view the full article, register now.
Already a subscriber? Click here to view full article